1. Home
  2. HWKN vs CPRX Comparison

HWKN vs CPRX Comparison

Compare HWKN & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HWKN
  • CPRX
  • Stock Information
  • Founded
  • HWKN 1938
  • CPRX 2002
  • Country
  • HWKN United States
  • CPRX United States
  • Employees
  • HWKN N/A
  • CPRX N/A
  • Industry
  • HWKN Specialty Chemicals
  • CPRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HWKN Consumer Discretionary
  • CPRX Health Care
  • Exchange
  • HWKN Nasdaq
  • CPRX Nasdaq
  • Market Cap
  • HWKN 2.6B
  • CPRX 2.5B
  • IPO Year
  • HWKN N/A
  • CPRX 2006
  • Fundamental
  • Price
  • HWKN $114.32
  • CPRX $22.78
  • Analyst Decision
  • HWKN Hold
  • CPRX Strong Buy
  • Analyst Count
  • HWKN 1
  • CPRX 7
  • Target Price
  • HWKN $122.00
  • CPRX $32.86
  • AVG Volume (30 Days)
  • HWKN 144.8K
  • CPRX 1.4M
  • Earning Date
  • HWKN 01-29-2025
  • CPRX 02-26-2025
  • Dividend Yield
  • HWKN 0.63%
  • CPRX N/A
  • EPS Growth
  • HWKN 18.72
  • CPRX 114.68
  • EPS
  • HWKN 3.91
  • CPRX 1.18
  • Revenue
  • HWKN $934,424,000.00
  • CPRX $460,482,000.00
  • Revenue This Year
  • HWKN $5.61
  • CPRX $23.98
  • Revenue Next Year
  • HWKN $7.54
  • CPRX $18.27
  • P/E Ratio
  • HWKN $29.26
  • CPRX $19.33
  • Revenue Growth
  • HWKN N/A
  • CPRX 32.17
  • 52 Week Low
  • HWKN $54.44
  • CPRX $13.12
  • 52 Week High
  • HWKN $139.55
  • CPRX $24.27
  • Technical
  • Relative Strength Index (RSI)
  • HWKN 41.27
  • CPRX 56.81
  • Support Level
  • HWKN $108.99
  • CPRX $21.23
  • Resistance Level
  • HWKN $116.83
  • CPRX $23.26
  • Average True Range (ATR)
  • HWKN 4.52
  • CPRX 1.14
  • MACD
  • HWKN -0.69
  • CPRX 0.20
  • Stochastic Oscillator
  • HWKN 38.33
  • CPRX 74.85

About HWKN Hawkins Inc.

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

Share on Social Networks: